Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russell Jones

Showing results (51-60 of 463) with videos related to

Pageof 47
Sort By:
The European Respiratory Journal|December 11, 2020
Intrapulmonary shunt measured by bedside pulse oximetry predicts worse outcomes in severe COVID-19Aleksandra Kotwica, Harry Knights, Nikhil Mayor, et al.
Accident and Emergency Nursing|November 29, 2007
An audit of the NICE self-harm guidelines at a local Accident and Emergency department in North WalesRussell Jones, Alison Avies-Jones
Clinical and Experimental Dermatology|July 13, 2004
Co-existence of lichen amyloidosus and angiolymphoid hyperplasia with eosinophiliaS Shankar, R Russell-Jones
Current Opinion in Endocrinology, Diabetes, and Obesity|May 26, 2010
The effect of growth hormone on pituitary tumour growthRoselle Herring, David Russell-Jones
Expert Opinion on Drug Delivery|March 19, 2011
Water-in-oil microemulsions for effective transdermal delivery of proteinsGregory Russell-Jones, Roy Himes
Clinical Endocrinology|July 19, 2012
Recent advances in incretin-based therapiesDavid Russell-Jones, Stephen Gough
The British Journal of Dermatology|February 17, 1999
Chronic endemic hydroarsenicismA Woollons, R Russell-Jones
Journal of the American Academy of Dermatology|April 21, 2004
Amelanotic lentigo maligna managed with topical imiquimod as immunotherapyAnn-Marie Powell, Robin Russell-Jones
Clinical and Experimental Dermatology|May 8, 1999
Acute dysarthria induced by low dose methotrexate therapy in a patient with erythrodermic cutaneous T-cell lymphoma: an unusual manifestation of neurotoxicityC G Aplin, R Russell-Jones
Lancet (London, England)|July 12, 2025
Use of once-weekly insulins for type 1 diabetesDavid Russell-Jones, David C Klonoff
Pageof 47

Showing results (51-60 of 463) with videos related to

Sort By:
Pageof 47
The European Respiratory Journal|December 11, 2020
Intrapulmonary shunt measured by bedside pulse oximetry predicts worse outcomes in severe COVID-19Aleksandra Kotwica, Harry Knights, Nikhil Mayor, et al.
Accident and Emergency Nursing|November 29, 2007
An audit of the NICE self-harm guidelines at a local Accident and Emergency department in North WalesRussell Jones, Alison Avies-Jones
Clinical and Experimental Dermatology|July 13, 2004
Co-existence of lichen amyloidosus and angiolymphoid hyperplasia with eosinophiliaS Shankar, R Russell-Jones
Current Opinion in Endocrinology, Diabetes, and Obesity|May 26, 2010
The effect of growth hormone on pituitary tumour growthRoselle Herring, David Russell-Jones
Expert Opinion on Drug Delivery|March 19, 2011
Water-in-oil microemulsions for effective transdermal delivery of proteinsGregory Russell-Jones, Roy Himes
Clinical Endocrinology|July 19, 2012
Recent advances in incretin-based therapiesDavid Russell-Jones, Stephen Gough
The British Journal of Dermatology|February 17, 1999
Chronic endemic hydroarsenicismA Woollons, R Russell-Jones
Journal of the American Academy of Dermatology|April 21, 2004
Amelanotic lentigo maligna managed with topical imiquimod as immunotherapyAnn-Marie Powell, Robin Russell-Jones
Clinical and Experimental Dermatology|May 8, 1999
Acute dysarthria induced by low dose methotrexate therapy in a patient with erythrodermic cutaneous T-cell lymphoma: an unusual manifestation of neurotoxicityC G Aplin, R Russell-Jones
Lancet (London, England)|July 12, 2025
Use of once-weekly insulins for type 1 diabetesDavid Russell-Jones, David C Klonoff
Pageof 47